Renee Laserna

Executive Director, Project Manager in HIV drug development with extensive experience leading complex, global, cross-functional programs from candidate selection through regulatory approval and lifecycle management. I integrate clinical, regulatory, CMC, commercial, supply, and device strategies into cohesive development plans that support disciplined decision-making at critical portfolio inflection points. Currently focused on advancing long-acting injectable HIV therapies, including combination product and autoinjector device development, I translate scientific innovation into executable strategy, lead teams through ambiguity and accelerated timelines, and balance risk, speed, and resource optimization to drive meaningful portfolio impact.

Project Manager on infectious disease, rare disease and dermatology assets ranging from early discovery to commit to file/ launch and marketed products. Previous experience in muscle metabolism, biopharmaceuticals. respiratory and stem cell projects. Utilizing Planisware, Hyperion, change control, integrating strategy/scope, timelines, budget and team communication/coordination with both internal GSK assets and alliance collaborations. Management of both holistic project/portfolio strategy and detailed work package activities and risk.

Pharmaceutical Development Project Manager for nanoparticle formulation development for both client assets and internal projects.

Phase III anti-platelet aggregating compound, Lotrafiban SAE reporting and CRF completions/closeout.

Steroid brain receptors (estrogen focus) discovery for women's health targets.

DNA vaccine development for HSV.

1991-1994: Immunology Department. ICE immunology and molecular biology development and analysis. 1986-1991: Neuroscience Department. Aminoalkylindole analgesic analysis.